Looking for a career in health economics and real-world evidence (RWE)? Check out the latest job openings in the pharmaceutical industry. There are many new opportunities available for RWE analysts, real-world evidence scientists, RWE managers, and real-world evidence market access managers in both pharmaceutical and life science consulting companies.
Shanghai, China. Hundreds of millions patients receive health care in China, and their records can help reimagine how integrated evidence generation will transform healthcare decision making. This is a pioneer role in the industry to drive the evidence excellence to improve patient access and outcomes in China. You will lead real world evidence (RWE) generation for Novartis strategic products 5 … Read more
Algiers, Algeria. We are looking for driven candidates seeking to launch their career in Health Economics and join our regional team based in Algiers, Algeria to help our clients improve their clinical, scientific and commercial results. You will work in a dynamic, global company of over 60,000 employees in more than 100 countries with a broad range of healthcare information, … Read more
Boston, MA, US. Reporting to the Head of the Real World Evidence Center of Excellence, the Senior Director of Real World Evidence is responsible for establishing rigorous assessment of real world data to assess the natural history of diseases and real world outcomes for the Vertex early development and clinical portfolio. The Senior Director of RWE will shape and influence … Read more
Casablanca, Morocco. We are looking for driven candidates seeking to launch their career in Health Economics and join our regional team based in Casablanca, Morocco to help our clients improve their clinical, scientific, and commercial results. You will work in a dynamic, global company of over 60,000 employees in more than 100 countries with a broad range of healthcare information, … Read more
Porto Salvo, Portugal. As an Analyst within the Real World Evidence Department, you will have a key role to support the HEOR practice. You are expected to be able to work in different projects for different clients on the Portuguese market. You will carry out your tasks to a high standard which meets or exceeds the client’s expectations. You will … Read more
London, UK. Putnam PHMR is seeking to hire a Director of Real-World Evidence [RWE]. This role offers the opportunity to join a global team of more than 40 epidemiologists, statisticians and economists. Our team works together to design and execute strategically and scientifically robust analyses utilising a variety of local and global real-world data sources. As a senior individual in … Read more
Raritan, NJ, US. Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson is recruiting for a Director, Global Real World Evidence (RWE) in our Global Commercial Strategy Organization (GCSO). The position is based in Raritan, NJ and will require up to 25% travel. The Director Global RWE will lead the strategy development and execution of industry leading RWE capabilities … Read more
Barcelona, Spain. Almirall is looking for a trainee to join our Real-World Evidence and Outcomes Research Department. The ideal candidate is an individual who has obtained a scientific degree as a pharmacist, physician, biologist, biotechnologist, etc. and is passionate about clinical studies. Tasks and Responsibilities: Education Essential: Desirable: Experience This job is posted by Almirall. APPLY FOR JOB This link … Read more
Basel, Switzerland / Raritan, NJ, US. Other location: Beerse, Belgium. We are looking for a Senior Director Market Access Analytics and Real-World Evidence (MAA & RWE) responsible for the development of MAA & RWE strategies to meet the needs of increasingly evidence-driven and cost-conscious HTA agencies around the world. The Senior Director leads a team that provides evidence that informs, complements, and confirms … Read more
Manila, Philippines / Bangkok, Thailand. Other location: Kuala Lumpur, Malaysia. Provides high quality, timely development and on-time input to client solutions for the pharmaceutical and related industries. Assignments range in complexity from basic analysis and problem solving to assisting in the development of more complex solutions to leading small teams. Principal Accountabilities: • Leverages business experience and acumen in identifying … Read more
Montreal, Canada. 46’000! That is the number of patients in clinical trials globally at Novartis. In addition to the 125+ globally sponsored studies run in Canada every year, there are another 50+ that are entirely designed and implemented end-to-end in Canada. As Real World Evidence (RWE) & Data Science Lead within the Health Research & Data (HR&D) team, you will … Read more
Raritan, NJ, US. Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson is recruiting for a Senior Director, Global Real World Evidence (RWE) in our Global Commercial Strategy Organization (GCSO). The position is based in Raritan, NJ and will require up to 25% travel. The Senior Director Global RWE will lead the strategy development and execution of industry leading … Read more
Singapore / Bangkok, Thailand. Other location: Wilayah Persekutuan Kuala Lumpur, Malaysia. Provides high quality, timely development and on-time input to client solutions for the pharmaceutical and related industries. Assignments range in complexity from basic analysis and problem solving to assisting in the development of more complex solutions to leading small teams. Principal Accountabilities: Carry out works relating to the HEOR … Read more
Tips and tricks to improve your CV and boost your health economics career. Are you tired of submitting countless job applications and never hearing back? Have you ever wondered why some job-seeking health economists seem to have all the luck? The answer is simple – they know how to create a winning CV that gets them hired. If you want … Read more
Real-World Evidence in Health Economics
Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.
What is Real-World Evidence?
Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.
RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.
Importance of Real-World Evidence in Health Economics
RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.
RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.
Differences between RWE and Randomized Controlled Trials (RCTs)
RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.
RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.
RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.
Methods of Collecting RWE
There are several methods of collecting RWE, including:
Electronic Health Records (EHRs) EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.
Claims Databases Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.
Registries Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.
Patient-Reported Outcomes (PROs) PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.
Surveys Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.
Advantages of Real-World Evidence
There are several advantages of using RWE in health economics research, including:
RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
RWE can be used to evaluate interventions in a variety of settings and patient populations.
RWE can provide information on the long-term effectiveness and safety of interventions.
RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.
Challenges and Limitations of Real-World Evidence
There are several challenges and limitations to using RWE in health economics research, including:
RWE can be subject to bias and confounding, which can affect the validity of the results.
RWE can be difficult to collect and analyze, particularly when using multiple data sources.
RWE may not be as well-suited for evaluating rare diseases or interventions.
Applications of Real-World Evidence
RWE has several applications in health economics research, including:
Health Technology Assessment Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.
Comparative Effectiveness Research Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.
Post-Marketing Surveillance Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.
Future of Real-World Evidence in Health Economics
RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.